Understanding Optimizing Drug Development With Model Informed Decision Making
Let's dive into the details surrounding Optimizing Drug Development With Model Informed Decision Making. Innovations in statistics, programming and data management are changing the very nature of clinical
Key Takeaways about Optimizing Drug Development With Model Informed Decision Making
- This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated
- Register for this webinar: ...
- Dr. Qi Liu, the Assoc. Director for Innovation & Partnership in the Office of Clinical Pharmacology, Office of Translational Sciences ...
- Rajesh Krishna, Senior Director with IDD Certara, reflects on how
- Roche pRED Clinical Pharmacology uses
Detailed Analysis of Optimizing Drug Development With Model Informed Decision Making
Making Clinical Pharmacologist Dr. Colin Pillai discusses if there are differences between an industry versus a regulatory setting, or if ... Certara is proud to partner with Fierce Pharma to bring you this on-demand webinar from October 11, 2022. Properly ...
Trial design
That wraps up our extensive overview of Optimizing Drug Development With Model Informed Decision Making.